173 related articles for article (PubMed ID: 34045667)
1. Gene expression signatures predict response to therapy with growth hormone.
Stevens A; Murray P; De Leonibus C; Garner T; Koledova E; Ambler G; Kapelari K; Binder G; Maghnie M; Zucchini S; Bashnina E; Skorodok J; Yeste D; Belgorosky A; Siguero JL; Coutant R; Vangsøy-Hansen E; Hagenäs L; Dahlgren J; Deal C; Chatelain P; Clayton P
Pharmacogenomics J; 2021 Oct; 21(5):594-607. PubMed ID: 34045667
[TBL] [Abstract][Full Text] [Related]
2. Validating genetic markers of response to recombinant human growth hormone in children with growth hormone deficiency and Turner syndrome: the PREDICT validation study.
Stevens A; Murray P; Wojcik J; Raelson J; Koledova E; Chatelain P; Clayton P;
Eur J Endocrinol; 2016 Dec; 175(6):633-643. PubMed ID: 27651465
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics of insulin-like growth factor-I generation during GH treatment in children with GH deficiency or Turner syndrome.
Stevens A; Clayton P; Tatò L; Yoo HW; Rodriguez-Arnao MD; Skorodok J; Ambler GR; Zignani M; Zieschang J; Della Corte G; Destenaves B; Champigneulle A; Raelson J; Chatelain P
Pharmacogenomics J; 2014 Feb; 14(1):54-62. PubMed ID: 23567489
[TBL] [Abstract][Full Text] [Related]
4. A pharmacogenomic approach to the treatment of children with GH deficiency or Turner syndrome.
Clayton P; Chatelain P; Tatò L; Yoo HW; Ambler GR; Belgorosky A; Quinteiro S; Deal C; Stevens A; Raelson J; Croteau P; Destenaves B; Olivier C
Eur J Endocrinol; 2013 Sep; 169(3):277-89. PubMed ID: 23761422
[TBL] [Abstract][Full Text] [Related]
5. GH deficiency status combined with GH receptor polymorphism affects response to GH in children.
Valsesia A; Chatelain P; Stevens A; Peterkova VA; Belgorosky A; Maghnie M; Antoniazzi F; Koledova E; Wojcik J; Farmer P; Destenaves B; Clayton P;
Eur J Endocrinol; 2015 Dec; 173(6):777-89. PubMed ID: 26340968
[TBL] [Abstract][Full Text] [Related]
6. Transcriptomics and machine learning predict diagnosis and severity of growth hormone deficiency.
Murray PG; Stevens A; De Leonibus C; Koledova E; Chatelain P; Clayton PE
JCI Insight; 2018 Apr; 3(7):. PubMed ID: 29618660
[TBL] [Abstract][Full Text] [Related]
7. Genetic predictors of long-term response to growth hormone (GH) therapy in children with GH deficiency and Turner syndrome: the influence of a SOCS2 polymorphism.
Braz AF; Costalonga EF; Trarbach EB; Scalco RC; Malaquias AC; Guerra-Junior G; Antonini SR; Mendonca BB; Arnhold IJ; Jorge AA
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1808-13. PubMed ID: 24905066
[TBL] [Abstract][Full Text] [Related]
8. Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS).
Blanco-López A; Antillón-Ferreira C; Saavedra-Castillo E; Barrientos-Pérez M; Rivero-Escalante H; Flores-Caloca O; Calzada-León R; Rosas-Guerra CC; Koledova E; Chiquete E; Ayala-Estrada A
J Endocrinol Invest; 2020 Oct; 43(10):1447-1452. PubMed ID: 32239476
[TBL] [Abstract][Full Text] [Related]
9. A pilot study to evaluate gene expression profiles in peripheral blood mononuclear cells (PBMCs) from children with GH deficiency and Turner syndrome in response to GH treatment.
Whatmore AJ; Patel L; Clayton PE
Clin Endocrinol (Oxf); 2009 Mar; 70(3):429-34. PubMed ID: 19018778
[TBL] [Abstract][Full Text] [Related]
10. Accurate long-term prediction of height during the first four years of growth hormone treatment in prepubertal children with growth hormone deficiency or Turner Syndrome.
Ranke MB; Lindberg A; Brosz M; Kaspers S; Loftus J; Wollmann H; Kołtowska-Haggstrom M; Roelants M
Horm Res Paediatr; 2012; 78(1):8-17. PubMed ID: 22832697
[TBL] [Abstract][Full Text] [Related]
11. Effects of growth hormone on cognitive function.
Ross JL
Horm Res; 2005; 64 Suppl 3():89-94. PubMed ID: 16439850
[TBL] [Abstract][Full Text] [Related]
12. Implications of a data-driven approach to treatment with growth hormone in children with growth hormone deficiency and Turner syndrome.
Kaspers S; Ranke MB; Han D; Loftus J; Wollmann H; Lindberg A; Roelants M; Kleintjens J
Appl Health Econ Health Policy; 2013 Jun; 11(3):237-49. PubMed ID: 23649890
[TBL] [Abstract][Full Text] [Related]
13. Observed and predicted total pubertal growth during treatment with growth hormone in adolescents with idiopathic growth hormone deficiency, Turner syndrome, short stature, born small for gestational age and idiopathic short stature: KIGS analysis and review.
Ranke MB; Lindberg A
Horm Res Paediatr; 2011; 75(6):423-32. PubMed ID: 21358173
[TBL] [Abstract][Full Text] [Related]
14. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
Al Shaikh A; Daftardar H; Alghamdi AA; Jamjoom M; Awidah S; Ahmed ME; Soliman AT
Acta Biomed; 2020 Mar; 91(1):29-40. PubMed ID: 32191651
[TBL] [Abstract][Full Text] [Related]
15. The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study.
Baş F; Darendeliler F; Aycan Z; Çetinkaya E; Berberoğlu M; Sıklar Z; Öcal G; Timirci Ö; Çetinkaya S; Darcan Ş; Gökşen Şimşek D; Bideci A; Cinaz P; Böber E; Demir K; Bereket A; Turan S; Atabek ME; Tütüncüler F; Isbir T; Bozkurt N; Kabataş Eryılmaz S; Uzunhan O; Küçükemre Aydın B; Bundak R
Horm Res Paediatr; 2012; 77(2):85-93. PubMed ID: 22456308
[TBL] [Abstract][Full Text] [Related]
16. GHR and VDR genes do not contribute to the growth hormone (GH) response in GH deficient and Turner syndrome patients.
Alvarez-Nava F; Marcano H; Pardo T; Paoli M; Gunczler P; Soto M; Villaloboss J; Lanes R
J Pediatr Endocrinol Metab; 2010 Aug; 23(8):773-82. PubMed ID: 21073120
[TBL] [Abstract][Full Text] [Related]
17. Effect of summer daylight exposure and genetic background on growth in growth hormone-deficient children.
De Leonibus C; Chatelain P; Knight C; Clayton P; Stevens A
Pharmacogenomics J; 2016 Nov; 16(6):540-550. PubMed ID: 26503811
[TBL] [Abstract][Full Text] [Related]
18. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
[TBL] [Abstract][Full Text] [Related]
19. Early cessation and non-response are important and possibly related problems in growth hormone therapy: An OZGROW analysis.
Hughes IP; Choong C; Rath S; Atkinson H; Cotterill A; Cutfield W; Hofman P; Harris M
Growth Horm IGF Res; 2016 Aug; 29():63-70. PubMed ID: 27179230
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency.
Jorge AA; Marchisotti FG; Montenegro LR; Carvalho LR; Mendonca BB; Arnhold IJ
J Clin Endocrinol Metab; 2006 Mar; 91(3):1076-80. PubMed ID: 16291702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
